key: cord-0910060-j3l56y5d
authors: Cooper, George M.; Kennedy, Matthew J.; Jamal, Bilal; Shields, David W.
title: Autologous versus synthetic bone grafts for the surgical management of tibial plateau fractures: a systematic review and meta-analysis of randomized controlled trials
date: 2022-03-14
journal: Bone Jt Open
DOI: 10.1302/2633-1462.33.bjo-2021-0195.r1
sha: ecd290d17e0f42e53af14f1e3d595e40fd1fe612
doc_id: 910060
cord_uid: j3l56y5d

AIMS: Our objective was to conduct a systematic review and meta-analysis, to establish whether differences arise in clinical outcomes between autologous and synthetic bone grafts in the operative management of tibial plateau fractures. METHODS: A structured search of MEDLINE, EMBASE, the online archives of Bone & Joint Publishing, and CENTRAL databases from inception until 28 July 2021 was performed. Randomized, controlled, clinical trials that compared autologous and synthetic bone grafts in tibial plateau fractures were included. Preclinical studies, clinical studies in paediatric patients, pathological fractures, fracture nonunion, or chondral defects were excluded. Outcome data were assessed using the Risk of Bias 2 (ROB2) framework and synthesized in random-effect meta-analysis. The Preferred Reported Items for Systematic Review and Meta-Analyses guidance was followed throughout. RESULTS: Six studies involving 353 fractures were identified from 3,078 records. Following ROB2 assessment, five studies (representing 338 fractures) were appropriate for meta-analysis. Primary outcomes showed non-significant reductions in articular depression at immediate postoperative (mean difference -0.45 mm, p = 0.25, 95%confidence interval (CI) -1.21 to 0.31, I(2) = 0%) and long-term (> six months, standard mean difference -0.56, p = 0.09, 95% CI -1.20 to 0.08, I(2) = 73%) follow-up in synthetic bone grafts. Secondary outcomes included mechanical alignment, limb functionality, and defect site pain at long-term follow-up, perioperative blood loss, duration of surgery, occurrence of surgical site infections, and secondary surgery. Mean blood loss was lower (90.08 ml, p < 0.001, 95% CI 41.49 to 138.67) and surgery was shorter (16.17 minutes, p = 0.04, 95% CI 0.39 to 31.94) in synthetic treatment groups. All other secondary measures were statistically comparable. CONCLUSION: All studies reported similar methodologies and patient populations; however, imprecision may have arisen through performance variation. These findings supersede previous literature and indicate that, despite perceived biological advantages, autologous bone grafting does not demonstrate superiority to synthetic grafts. When selecting a void filler, surgeons should consider patient comorbidity, environmental and societal factors in provision, and perioperative and postoperative care provision. Cite this article: Bone Jt Open 2022;3(3):218–228.

Fractures of the tibial plateau, although relatively uncommon with a global yearly incidence of 10.3 per 100,000 people, have substantial and deleterious impacts on patients' quality of life. [1] [2] [3] Two distinct mechanisms of injury are observed: high-energy trauma in younger patients and low-energy trauma in osteopenic patients. [1] [2] [3] In both settings, there is significant risk of malunion, early osteoarthritis, and deep infection, which is severely debilitating in younger patients. [4] [5] [6] Classification of tibial plateau fracture patterns, most commonly with Schatzker or AO/OTA nomenclature, indicate the degree of anatomical stability, and thus inform management strategies. [6] [7] [8] [9] [10] The span of injury patterns, both bony and soft-tissue, results in a wide variety of treatment methods and outcomes. Operative managements of complex fractures (AO/OTA 41 C1,2,3; Schatzker IV-VI) include uni-/bicondylar fixation, arthroplasty, or external fixation in soft-tissue injury. 6, 9, [11] [12] [13] Treatment seeks to achieve a stable, mechanically aligned leg with restoration of the joint surface. 2, 3 Subsequently, in these complex fractures, bone grafting may support this reduction. 3 Bone grafting is indicated to augment the open reduction and internal fixation of intra-articular tibial plateau fractures, improving the mechanical environment and promoting bone growth within the fracture defect void. [14] [15] [16] Historically, autologous bone grafting 2008 to 2012 Sweden 1 11, 9 11, 9 48 (ABG), typically from the anterior iliac spine, has been preferred given its proposed structural and osteogenic properties. 14 However, this intervention is not without significant complication profiles, both at the recipient fracture site and the site of bone graft harvest. 17, 18 Additional donor site morbidity is associated with an 8.6% risk of major complications, including infection and reoperation. 18 Furthermore, following anterior iliac spine graft harvesting, approximately 40% of patients will still suffer from pain six-months postoperatively. 19 Subsequently, interest in synthetic bone graft substitutes has increased over recent decades, underpinned by translational research into advanced, bioengineered, biomaterials. 20 Animal studies have demonstrated the biomechanical superiority of calcium phosphate cements relative to cancellous ABG in maintaining the reduction of depression following intra-articular tibial plateau defects. 21 Cadaveric studies corroborate this biomechanical advantage, demonstrating improved stiffness and decreased displacement in synthetic bone grafts. 22 Despite the perceived advantages of an improved mechanobiological environment and no donor site morbidity, to date there is limited highquality clinical evidence to warrant the perceived additional costs of synthetic grafts.

This meta-analysis aims to assimilate the relevant high-quality randomized controlled trials (RCTs) to ascertain whether ABGs demonstrate clinical superiority to synthetic bone grafts in the management of tibial plateau fractures.

Protocol and registration. This systematic review and meta-analysis was undertaken in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 23 guidance and the Cochrane Handbook for Systematic Reviews of Interventions. 24 The review protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO) database on 7 September 2021 (accessible under CRD42021270073). Ethical approval and informed consent were not required for this research. Eligibility criteria. Eligibility criteria were considered with respect to the population, intervention, comparator, outcome and study design (PICOS) framework. 24 We interrogated reported populations of tibia plateau fractures patients, to compare the use of synthetic bone substitutes with the standard of care ABG in RCTs. 16, 17 Our primary outcome was postoperative articular depression. Secondary outcomes included mechanical alignment, satisfaction with reduction, return to functionality, perioperative blood loss, duration of surgery, defect site pain at long-term follow-up and frequencies of defect site infections and secondary surgical interventions.

In vitro or cadaveric experiments, and observational and non-randomized clinical studies were ineligible, ensuring the highest applicability to clinical practice. Studies investigating tibial plateau fractures in patients under 16 years old, benign or malignant bone tumours, or fracture nonunion were also excluded, as were studies exploring chondral defect repair. We searched databases from their inception to 28 July 2021. When indicated, we requested manuscripts from non-English language publications and unpublished literature. These were only excluded if the corresponding authors did not respond. Information sources and search strategy. Our search strategy (Supplementary Table i) was executed on the "MEDLINE(R) and In-Process, In-Data-Review & Other Non-Indexed Citations 1946 to July 28th, 2021", "EMBASE 1980 to 2021 Week 30", and "Cochrane Central Register of Controlled Trials" databases. This was augmented by a further Boolean search: "Tibia Plateau Fracture AND (Bone Substitute OR Bone Graft)" on the National Institute of Health Clinical Trials Registry and the Bone and Joint Database. Manual reference list screening was performed on all relevant reviews and included articles. Study selection and risk of bias assessment. After deduplication, 3,078 records were screened by at least two reviewers (GC and MK). Disagreements between reviewers were resolved by the senior author (DS).

Cohen's kappa was calculated to assess inter-rater reliability between reviewers. 25 Risk of bias was assessed using the contemporaneous Cochrane Risk of Bias 2 (ROB2) tool. 26 The overall risk of bias was assessed for each set of outcome data included in our synthesis and was ascribed, according to its worst domain, as either low-risk, some concerns, or high-risk. High-risk outcome data were excluded from our synthesis. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was used to assess the certainty of each assimilated outcome. 27 Data collection process, data items, and effect measures. Data relating to the primary and secondary outcomes was extracted from each article under the observation of at least one other author. Where necessary, any further or missing outcome data was requested from corresponding authors. We sought further descriptive population-level values for study treatment groups (e.g. sample size, mean patient age, and proportion of female sex) and to capture possible ascertainment biases and indicate sources of heterogeneity. We defined the immediate postoperative period as any time within the contiguous two weeks and long-term follow-up, as the last reported measurements, taken at least six months postoperatively.

Continuous outcomes were directly compared by mean difference and 95% confidence intervals (CIs). Similarly, discontinuous outcomes were compared by calculating odds ratio (OR) and 95%CIs.

Where outcomes were reported as continuous or discontinuous measurements between studies, we contacted the authors for continuous outcome data. If necessary, standard mean differences (SMD) and corresponding standard error (SE) of discontinuous outcome data were calculated from ORs and 95% CIs using Chinn's method. 28 This approach is recommended by the Cochrane Handbook for Systematic Review of Intervention and summarized in Supplementary Methods 1. 28 Where necessary, standard deviation (SD) was imputed from sample range value using Wan et al's 29 adaptive method, outlined in Supplementary Methods 2. Statistical analysis. Pairwise meta-analyses were performed using an inverse-variance, random effects model. The corresponding forest plots were generated using Review Manager v. 5.4 (The Cochrane Collaboration, UK). 30 Heterogeneity was assessed according to the I 2 statistic. Post-hoc sensitivity analysis was indicated in assimilations of three or more studies, where heterogeneity was, at least, moderate (I 2 > 30%). 24 A prespecified subgroup was assembled from synthetic, calcium phosphate cement (CPC), substitutes. Post-hoc, we identified bioactive glass granule and porous titanium granule subgroups. Subgroup analyses were also conducted in Review Manager 5.4 using the Χ 2 function. 30

Following de-duplication, 3,078 records were identified. After screening and manuscript assessment, six studies were initially identified in our review ( Figure 1 ). [31] [32] [33] [34] [35] [36] Interrater reliability indicated substantial agreement (Cohen's k = 0.72). 26 Additional information on almost-eligible studies is presented in Supplementary Results 1.

The selected RCTs represent 353 fractures across 352 patients from 1989 to 2019. 31 One study was set in the USA, one in both Canada and the USA, and four across Northern or Central Europe (Table I) . Study populations and treatment arms were directly comparable. [31] [32] [33] [34] [35] [36] 

Forest plot of mechanical alignment outcome data, comparing the tibiofemoral angle of injured/uninjured lower limbs from patients in three studies. 32 33 However, it included a substantive loss of subjects to follow-up (approximately 50%), which exacerbated attrition bias. 33, 34 Thus, our study selection process identified five studies (comprising 338 fractures) suitable for meta-analysis ( Figure 1 ).

Following patient randomization according to the date of presentation, the unblinded nature of Bucholz et al 31 represents clear loss of allocation concealment, introducing concerns around ascertainment biases. 26 Despite this, the baseline characteristics of both groups were highly comparable, indicating researchers' equipoise and limiting the magnitude of these concerns.

Both Hofmann et al 36 and Russell et al 32 reported partial or complete missing data in approximately 15% of patients randomized. These were primarily attributed to loss to follow-up. Given the challenges associated with maintaining patient engagement in large surgical trials, we did not feel these indicated a particular risk of bias. 26, 32, 36 The small number of studies precluded assessment of publication bias with Egger's test. 24 The certainty of each synthesized outcome, as determined by the GRADE framework, is presented in Supplementary Table iii. 27 articular depression and mechanical alignment. All RCTs included in our synthesis reported on articular reduction, which was measured with anteroposterior radiographs. [31] [32] [33] 35, 36 An absence of statistically improved reduction was observed by three studies at immediate postoperative follow-up, with pooled analysis observing a non-significantly smaller malreduction with the use of synthetic grafts (mean difference -0.45 mm, p = 0.25, 95% CI -1.21 to 0.31, I 2 = 0%, Figure 2a) . 31, 33, 35 Bucholz et al 31 was the only study included in this outcome analysis without a low overall risk of bias. Here, some concerns were attributed to the ascertainment of treatment groups and uncertainty as to whether radiological outcome data collection was blinded. 26 When comparing synthetic grafting to ABG, a statistically non-significant improvement in articular reduction was observed in long-term (> six months) follow-up analysis of four studies, each with low overall risks of bias (SMD -0.56, p = 0.09, 95% CI -1.20 to 0.08, I 2 = 73%, Figure 2b ). 32,34-36 Sensitivity analyses (Figures 3a and 3b) implicate both Russell et al 32 Pernaa et al 34 reported mean postoperative articular depression of 1.4 mm (0 to 2) in the bioactive glass and 1.6 mm (0 to 5) in the ABG groups, respectively. Similarly, at final follow-up (mean 11 years; 10 to 14), articular depression was 1.4 mm (0 to 2) and 1.4 mm (0 to 4) in the bioactive glass and ABG groups; indicating, despite its high risk of bias, extended long-term efficacy of bioactive glass void filler. 26, 33, 34 Mechanical alignment at long-term follow-up was compared radiologically in three studies, demonstrating insignificant differences in alignment when compared to the other leg using weightbearing, anteroposterior radiographs (SMD -0.26, p = 0.15, 95% CI -0.62 to 0.09, I 2 = 0%, Figure 4) . 32, 33, 36 This finding correlates with Pernaa et al, 34 which reported no significant mean contralateral (affected/unaffected knee) differences in the tibiofemoral angle in the bioactive glass and ABG groups. All studies assimilated in this outcome had a low overall risk of bias. Overall certainty in the quality of these three outcomes was high, according to our GRADE analysis (Supplementary Table iii ). 27 anticipated adverse events. Defect site pain at longterm follow-up was extracted from three studies. 31, 33, 35 Two of these studies had had high overall risks of bias, Jónsson and Mjöberg 35 identified a non-significant signal for reduced long-term defect site pain between synthetic substitutes and ABG (OR 0.34, p = 0.27, 95% CI 0.05 to 2.26). Overall certainty in this outcome was moderate (Supplementary Table iii), following the relative imprecision in the context of the demonstrable patient impact, and additional concerns of information biases arose following unblinded data collection; however, these concerns were limited by an acceptable, standardized methodology. 26, 27, 35 Small but statistically significant reductions in duration of surgery and blood loss were observed. Assimilation of two studies identified this reduction in surgery duration (mean difference 16.17 minutes, p = 0.04, 95% CI 0.39 to 31.94, I 2 = 63%, Figure 5a ). 35, 36 Similarly two different studies identified the reduction in blood loss (mean difference 90.08 ml, p < 0.001, 95% CI 41.49 to 138.67, I 2 = 0%, Figure 5b ). 33, 36 All studies synthesized for these two outcomes showed low risk of bias in their respective outcomes. 26 Overall certainty in the quality of both these outcomes was high, according to our GRADE analysis (Supplementary Table iii ). 27 unanticipated adverse events. A synthesis of four studies accumulated data on 294 fractures, giving an overall surgical site infection rate of 2.7% (8/294) (Figure 6a ). [31] [32] [33] 36 Pooled analysis revealed no difference between substitutes and ABG (OR 0.72, p = 0.58, 95% CI 0.18 to 2.94, I 2 = 0%). In Pernaa et al, 34 one patient in the ABG group developed a mild wound infection but none did from the bioactive glass group (OR 0.63, p = 0.79, 95% CI 0.02 to 18.37) , showing no significant difference from the consensus of analyzed literature.

Three studies (representing 174 fractures) comprehensively reported secondary surgical interventions throughout their follow-up period (Table I) , which are summarized in Supplementary Table iv. 31, 32, 36 These showed a combined occurrence rate of 4.3% (7/164) and a statistically non-significant signal towards increased frequency in patients receiving ABG, relative to the synthetic bone substitute group (OR 0.66, p = 0.53, 95% CI 0.13 to 3.34, I 2 = 0%, Figure 6b ). Noticeably, Russell et al 32 reported no secondary surgical interventions in both treatment groups, and thus this studies effect size could not be estimated or assimilated.

In both outcomes, the concerns around population ascertainment in Bucholz et al 31 were the only potential risks of bias identified. 32, 33, 35, 36 Following outcome imprecision, in the context of demonstrable patient impact, overall certainty in the quality of both frequency of surgical site infection and secondary surgical We elected not to synthesize these measures, given the overlapping patient groups and high attrition in Pernaa et al. 34 Furthermore, both patient populations were unblinded, introducing possible information biases. Both studies reported no significant differences in "Excellent" results (Heikkilä et al 33 Jónsson and Mjöberg 35 found no significant difference in Lysholm knee score at 12 months between ABG and synthetic grafts (mean difference 2.920, p = 0.65, 95% CI -10.2465 to 16.0874). Finally, Hofmann et al 36 graphically presented quality of life and functionality using the 12-item short form survey (SF-12) mental and physical component summaries, respectively. Although these data could not be extracted, no clinically or statistically significant difference between synthetic and ABG treatments were observed. 36

While it is widely accepted that open reduction and internal fixation of complex tibial plateau fractures is the gold standard for management, it is often assumed that the presence of a metaphyseal void mandates immediate surgical intervention with void filler. 6, 11, [15] [16] [17] [18] 32, 37, 38 However, biomechanical studies do not replicate the evolving scenario seen with fracture healing, and there remain no quality in vivo experiments that replicate the biomechanics of a bipedal plateau void. 39 Historically, ABG has been considered the preferred defect void filler, given its proposed satisfaction of ideal biological, mechanical, and economic criteria for bone grafts. [14] [15] [16] 31, [40] [41] [42] [43] However, harvesting ABGs imparts additional morbidity. [17] [18] [19] 44 Structural concerns surround the relatively low density of cancellous iliac bone, exacerbating resorption in acute injury and impairing the maintenance of reduction. 45 Furthermore, a recent systematic review concluded that, despite ongoing research, there is currently insufficient evidence to elucidate the utility of biologically active bone grafts in fracture healing. 46 Indeed, consensus indicates that synthetic bone grafts may provide a viable alternative void filler in the setting of tibial plateau fractures. [31] [32] [33] [34] [35] [36] [37] 40, [47] [48] [49] This meta-analysis represents the most contemporary synthesis of high-quality (Oxford Centre for Evidence-Based Medicine, OCEBM, Level 1), randomizedcontrolled literature comparing synthetic and autologous bone grafts for tibial plateau fractures, and supersedes a previous systematic review containing lower-level literature. 40, 50 The primary outcomes of this analysis indicate non-significant signals towards increased accuracy of initial surgical reduction and the preservation of articular reduction at the long-term (> six months) follow-up period, when comparing synthetic and autologous grafts. This is consistent with the limited mechanical characteristics of ABGs, relative to synthetic grafts in preclinical literature. 51, 52 The substantial heterogeneity (I 2 = 73%) in long-term articular reduction was driven by two factors. Firstly, a large magnitude of effect attributed to titanium granules perhaps indicates resilience towards early resorption. 35 Secondly, despite both being pragmatic, comparable RCTs, Russell et al 32 Small but significant improvements in duration of surgery and blood loss were observed in synthetic bone grafts, relative to ABGs, when measured. The magnitude of these (16.17 minutes and 90.08 ml) are consistent with graft harvesting in previous literature. [17] [18] [19] 45, 53 The heterogeneity identified in duration of surgery may arise from differences in study setting, including procedural familiarity and local incidences between the single-centre in Jónsson and Mjöberg, 35 and the multicentre Hofmann et al. 36 Alternatively, it may indicate greater simplicity in the application of titanium granules relative to biphasic calcium phosphate and sulphate cements. 35, 36 Regardless, these findings have implications for contemporary practice, representing marginal but statistically significant gains in perioperative morbidity and, in this context, demonstrating the non-inferiority of synthetic grafting. Blood loss is a key surgical morbidity, and reduced duration of surgery impacts provision of both orthopaedic and anaesthetic services, especially given widespread increased systemic pressures around the COVID-19 pandemic, the additional morbidity associated with prolonged anaesthesia, and environmental concerns surrounding inhaled anaesthetics. [54] [55] [56] [57] Three studies reported on mechanical alignment, which may be predictive of impaired long-term functionality and subsequent development of osteoarthritis, at follow-up, and concluded there was no difference in alignment between synthetic and autologous bone grafts. 32, 33, 35, 47, 58 Functional outcome data in our evidence base was limited and showed no preference for synthetic or autologous bone grafts. There were non-significant differences in measured adverse event outcomes -specifically pain -frequency of surgical site infection, or in adverse events that required secondary surgery, which favoured synthetic rather than autologous grafts. Subsequently, we could not observe statistical divergence in the adverse event profiles of the graft types we explored; however, delayed synthetic graft resorption might be reasonably expected in synthetic bone graft subtypes. 20, 59 Despite its importance to patients and prominence in epidemiological literature, there was limited high-quality reporting of long-term defect site pain. [1] [2] [3] [4] [5] 31, 34, 35 Measures of patient-reported functional outcomes and quality of life, which are at the core of contemporary orthopaedic research, were highly heterogenous in our evidence base and thus limited assimilation. 60 Furthermore, there is a noticeable lack of outcome data beyond 12 months and cost-benefit analyses, limiting comparison of these treatments in these contexts. These shortcomings indicate the need for a further, large-scale, pragmatic RCT in this setting to consolidate these limitations in the literature. In the setting of advancing synthetic graft materials and the adverse effects of autologous grafting, researchers may also seek to compare osteosynthesis using synthetic grafts versus fixation alone. [17] [18] [19] [20] 59, 61, 62 In this case, it will be important for the pragmatic design of this trial to optimize the selection of .

It should not be concluded that synthetic void fillers are superior to ABGs. Instead, we suggest that the biological attributes of ABG provide little measurable benefit to tibial plateau fracture patients. There are several key limitations to our study. As with many RCTs, there is often an unseen selection bias which can be compounded by meta-analysis. 61 In this case, patients are more likely to be included in trials who have larger defect voids and more complex fracture patterns. Consequently, while these results are not likely generalizable to the wider setting of tibial plateau fractures (where bone grafting is less frequently indicated), this self-selection may act to limit variation in fracture patterns within study populations, thus maintaining the internal validity of this review. 3 Furthermore, surgeons with a certain preference or familiarity with a particular graft may introduce performance biases. 63 Additionally, postoperative variation arises between geographical and temporal variance in rehabilitation pathways, and the psychosocial and economic factors determining patient engagement within these pathways introduce heterogeneity when comparing long-term outcomes. However, sampled study population samples were drawn from more economically developed countries. [31] [32] [33] [34] [35] [36] While limiting the applicability of study findings to patients in less economically developed countries, this contributes to homogeneity when comparing studies in this synthesis. Furthermore, all but one study was actively recruiting patients between 1999 and 2009, this temporal distribution again supporting internal validity. [31] [32] [33] [34] [35] [36] Although sampling databases from inception, and thus including Bucholz et al, 31 may have introduced some historical practice variation, this study explored hydroxyapatite as a synthetic bone graft, which is still used contemporaneously. , 64, 65 Finally, a wide variety of graft options have been included in this review, possibly introducing heterogeneity to the synthetic treatment group. These factors, in combination with our small number of assimilated studies, may limit the power of our analysis and increase exposure to publication bias. However, pragmatically, this synthesis still presents the highest quality (OCEBM, Level 1) evidence in this setting. 50, 63 In conclusion, this meta-analysis challenges the longheld paradigm that the gold standard for void management in tibial plateau fractures is ABG. [14] [15] [16] Our findings indicate that if a surgeon selects a synthetic bone graft to supplement fixation of a tibial plateau fracture, they can expect an equivalent accuracy of initial reduction and maintenance of long-term reduction, alongside minor reductions in operating time and blood loss. Subsequently, in this setting, surgeons should select void fillers while considering patient morbidity and operating time in surgical care provision. However, future research is needed to elucidate the optimal method in the surgical management of bone voids in tibial plateau fractures.

-This analysis challenges the accepted paradigm that autologous bone grafting provides the gold standard of care, relative to synthetic bone grafts, in the management of complex tibial plateau fractures. -Small but statistically significant reductions in mean perioperative blood loss and mean operating time were associated with synthetic bone grafting, while maintenance of reduction, pain, functionality, and adverse event profiles were statistically similar between treatment groups. -In the management of complex tibial plateau fractures, surgeons should select void-filler based on wider considerations such as patient multimorbidity and systemic factors.

Follow G. M. Cooper @GCooper_2000 Follow M. J. Kennedy @mjkennedy_1 Follow D. W. Shields @dwshields

The supplementary material contains additional information on our statistical methodology and outlines the literature search undertaken. It also summarises the excluded studies, the risk of bias evaluations (ROB2) of included studies and the certainty of evidence (GRADE) evaluation for synthesised outcomes. Finally, the complete list of adverse events from our literature sample is presented.

Population-based epidemiology of tibial plateau fractures

Tibial plateau fractures: definition, demographics, treatment rationale, and long-term results of closed traction management or operative reduction

Skeletal Trauma: Basic Science, Management, and Reconstruction

Complications after tibia plateau fracture surgery

Complications of internal fixation of tibial plateau fractures

The tibial plateau fracture. The Toronto experience

Injury severity assessment in tibial plateau fractures

Classifications in brief: Schatzker classification of tibial plateau fractures

Orthopaedic Trauma Association. Fracture and dislocation compendium. orthopaedic trauma association committee for coding and classification

3D mapping and classification of tibial plateau fractures

Prediction of soft-tissue injuries in Schatzker II tibial plateau fractures based on measurements of plain radiographs

Tibial plateau fractures: a study of associated soft tissue injuries

Surgical fixation methods for tibial plateau fractures

Tibial plateau fractures: evaluation and treatment

Autologous bone graft in the treatment of post-traumatic bone defects: a systematic review and metaanalysis

Tibial plateau fractures: management and expected results

Harvesting autogenous cancellous bone graft from the anterior iliac crest

Morbidity at bone graft donor sites

Autogenous iliac crest bone graft. complications and functional assessment

Materials design for bone-tissue engineering

Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft

Comparative fixation of tibial plateau fractures using alpha-BSM, a calcium phosphate cement, versus cancellous bone graft

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Cochrane Handbook for Systematic Reviews of Interventions Version 6

A coefficient of agreement for nominal scales

RoB 2: a revised tool for assessing risk of bias in randomised trials

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

A simple method for converting an odds ratio to effect size for use in metaanalysis

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

The Cochrane Collaboration

Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures

Plateau Fracture Study Group. Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. A multicenter, prospective, randomized study

Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study

Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures -a prospective randomized 11-year follow-up

Porous titanium granules are better than autograft bone as a bone void filler in lateral tibial plateau fractures: A randomised trial

Autologous iliac bone graft compared with biphasic hydroxyapatite and calcium sulfate cement for the treatment of bone defects in tibial plateau fractures: a prospective, randomized, open-label, multicenter study

Tibial plateau fractures. An analysis of the results of treatment in 60 patients

Fractures of the tibial plateau: a review of ninety-five patients and comparison of treatment methods

Bone defect animal models for testing efficacy of bone substitute biomaterials

Use of bone graft substitutes in the management of tibial plateau fractures

Autologous bone graft: is it still the gold standard?

Bone-graft substitutes: facts, fictions, and applications

Fracture healing: the diamond concept

Complication of anterior iliac bone graft harvesting in 372 adult patients from may 2006 to may 2011 and a literature review

Comparison of bone grafts from various donor sites in human bone specimens

Systematic review assessing the evidence for the use of stem cells in fracture healing

Outcome of tibial plateau fractures managed with calcium phosphate cement

Calcium sulfate cement in contained traumatic metaphyseal bone defects

Three year followup from a prospective study

Limitations of autograft and allograft: new synthetic solutions

Mechanical behavior of human morselized cancellous bone in triaxial compression testing

The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials

Anesthesia duration as an independent risk factor for early postoperative complications in adults undergoing elective ACDF

Quantifying the backlog of total hip and knee arthroplasty cases: predicting the impact of COVID-19

Environmental sustainability in anaesthesia and critical care

The orthopaedic waiting list crisis

Coronal tibial slope is associated with accelerated knee osteoarthritis: data from the Osteoarthritis Initiative

Bone grafts and biomaterials substitutes for bone defect repair: a review

Patient reported outcomes in orthopaedics

Contact stress aberrations following imprecise reduction of simple tibial plateau fractures

Tibial plateau fractures treated with plate fixation: to lock or not to lock

Use of an injectable calcium phosphate bone cement in the treatment of tibial plateau fractures: a prospective study of twenty-six cases with twenty-month mean follow-up

Fixation of tibial plateau fractures with synthetic bone graft versus natural bone graft: a comparison study

PhD, FRCS (Tr & Ortho)., Orthopaedic Surgeon and Honorary Clinical Lecturer Division of Limb Reconstruction, Department of Trauma and Orthopaedic Surgery

Investigation, Methodology, Writing -original draft, Writing -review & editing

Conceptualization, Writing -review & editing

Shields: Conceptualization, Data curation, Project administration, Supervision, Investigation, Methodology, Writing -review & editing

The authors received no financial or material support for the research, authorship, and/or publication of this article.

D. W. Shields and B. Jamal report a research grant from Biocomposites, unrelated to this study. B. Jamal also reports a speaker payment from Biocomposites, unrelated to this study. B. Jamal is also a council member of the Royal College of Physicians and Surgeons of Glasgow Executive committee, the British Limb Reconstruction Society Trauma Committee, and the British Orthopaedic Association.

The authors confirm that the open access funding for this study was self-funded.